Cole JA, Farraye FA, Cabral HJ, Zhang Y, Rothman KJ. Irritable bowel syndrome and hysterectomy: a sequence symmetry analysis. Epidemiology. 2007 Nov 1;18(6):837-8.
Iyer S, Candrilli SD, Davis KL. Patterns of opioid use, opioid-related side effects and resource utilization in cancer patients on chronic opioid therapy with constipation versus matched controls without constipation. Poster presented at the Scientific Symposium of the National Hospice and Palliative Care Organization; November 2007.
Mitra D, Davis KL, Baran RW. Healthcare costs and clinical sequelae associated with constipation in a managed care population. Poster presented at the Annual Scientific Meeting of the American College of Gastroenterology; October 2007.
Mitra D, Baran RW, Davis KL. Medical service and prescription drug charges before and after initial diagnosis among managed care patients with constipation. Poster presented at the Educational Conference of the Academy of Managed Care Pharmacy; October 2007.
Candrilli SD, Iyer S, Davis KL. Impact of constipation on health care utilization and costs in patients on opioid therapy. Poster presented at the 2007 ISPOR 10th Annual European Congress; October 2007. Dublin, Ireland.
Johnson FR, Ozdemir F, Mansfield CA, Hass S, Miller DP, Siegel CA, Sands BE. Crohn's disease patients' benefit-risk preferences: serious adverse event risks versus treatment efficacy. Gastroenterology. 2007 Sep;133(3):769-79.
Davis KL, Candrilli SD, Iyer S. Impact of constipation on resource utilization and costs in non-metastatic cancer patients on opioid therapy. Poster presented at the Annual Clinical Meeting of the American Academy of Pain Management; September 2007.
Earnshaw SR, McDade CL, Mangel AW, Baran RW. Cost-effectiveness of lubiprostone in a managed care population with chronic idiopathic constipation. Poster presented at the 2007 ACG Annual Meeting; September 2007. [abstract] Am J Gastroenterol. 2007 Sep; 102(S2):S449-50.
Iyer S, Candrilli SD, Davis KL. Opioid use patterns, health care utilization, and costs in metastatic cancer patients on chronic opioid therapy with constipation compared to patients without constipation. Poster presented at the 14th European Cancer Conference; September 2007.
Dickinson KL, Pattanayak SK, Yang J, Patil SR, Praharaj P, Mallick RK, Blitstein JL, Poulos C. Nature's call: can social mobilization promote toilet use and reduce child diarrhea? Results from a community randomized trial in Orissa, India. Presented at the Infectious Diseases Conference at Cornell University; September 2007.
Camilleri M, Mangel AW, Fehnel SE, Drossman DA, Mayer EA, Talley NJ. Primary endpoints for irritable bowel syndrome trials: a review of performance of endpoints. Clin Gastroenterol Hepatol. 2007 May 1;5(5):534-40.
Mitra D, Davis KL, Baran R. Health care utilization and costs associated with constipation (C-ONLY) and co-occurring irritable bowel syndrome and constipation (IBS+C) compared to migraine in a large managed care population. Poster presented at the 2007 ISPOR 12th Annual International Meeting; May 22, 2007. [abstract] Value Health. 2007 May; 10(3):A148-9.
Mitra D, Davis KL, Baran RW. Healthcare utilization and costs associated with constipation and co-occurring irritable bowel syndrome and constipation compared to matched controls in a large managed care population. Poster presented at the 2007 Digestive Disease Week; May 2007.
Mangel AW, Fehnel SE. Adequate relief: the gold standard primary endpoint in IBS. Presented at the 2007 Digestive Disease Week; May 1, 2007.
Dickinson KL, Pattanayak SK, Yang J, Patil SR, Praharaj P, Mallick RK, Blitstein JL, Poulos C. Nature's call: can a social mobilization campaign lead households to use toilets and reduce diarrhea? Results from a randomized trial in Orissa. Poster presented at the 4th Minnesota International Economic Development Conference at the University of Minnesota; May 2007.
Mahajan S, Fehnel SE, Thompson M, Minnich M, Northcutt A, Bell T. Comparing the effects of irritable bowel syndrome on work productivity and healthcare utilization with those of asthma and migraine: results from a web-based patient survey. Presented at the 2007 Digestive Disease Week; May 1, 2007.
Mahajan S, Davis KL, Minnich M, Northcutt A, Bell T. The direct and indirect economic costs of irritable bowel syndrome in a large US employer population. Poster presented at the 2007 Digestive Disease Week; May 2007.
Cook SF, Bell TJ, Sweeney CT, Goss DS, Zhou X. Severity of constipation-associated gi symptoms related to opioid treatment in chronic pain patients: pac-sym questionnaire results from the opioid survey. Poster presented at the 26th Annual Scientific Meeting of the American Pain Society; May 2007.
Cook SF, Bell T, Sweeney CT, Fehnel SE, Hollis KA. Impact on quality of life of constipation associated gi symptoms related to opioid treatment in chronic pain patients: pAC-QoL results from the opioid survey. Poster presented at the 26th Annual Scientific Meeting of the American Pain Society; May 2007.
Varas-Lorenzo C, Maguire A, Castellsague J, Perez-Gutthann S. Quantitative assessment of the gastrointestinal and cardiovascular risk-benefit of celecoxib compared to individual NSAIDs at the population level. Pharmacoepidemiol Drug Saf. 2007 Apr 1;16(4):366-76.
Cole JA, Rothman KJ, Cabral HJ, Zhang Y, Farraye FA. Incidence of IBS in a cohort of people with asthma. Dig Dis Sci. 2007 Feb 28;52(2):329-35.
Tennis P, Andrews E, Hickman P, Miller D, Hollis KA, Cook S. The relationship between dosing of alosetron and discontinuation patterns reported by patients participating in a follow-up programme. Aliment Pharmacol Ther. 2007 Feb 1;25(3):317-22.